Drug reps push ineffective drugs to meet sales targets

An appalling new report proves that your typical drug sales rep isn’t pitching your doctor on drugs that could save lives — or even improve your health. He’s trying to blow out the ineffective, under-performing drugs, like the diabetes drug Victoza, which aren’t making their sales targets.

According to this latest report, more often than not, sales reps weren’t marketing breakthrough therapies or new, promising treatments. Instead, they were trying to get a foothold for drugs that were failing in the market and making investors nervous. In most cases, there were already cheaper and more effective drugs on the market.

A case in point, Novo Nordisk spent $9 million at the end of 2013 trying to sell doctors on the merits of Victoza — the once-daily medicine that supposedly improves blood sugar levels in adults with type 2 diabetes… and it comes with a long list of debilitating side effects, including cancer.

Not exactly a drug that sells itself, if you know what I’m saying.

Victoza is such a potentially dangerous drug that there was public outcry when the FDA approved it a few years back.

So, remember that the next time some mainstream doctor is singing the praises of some “exciting new drug” he just heard about, it’s quite possible that you’re being flogged a drug that is dangerous and ineffective.

Wishing you the best of health,

Dr. Jonathan V. Wright
Nutrition & Healing
Did you find this information useful?

If you enjoyed this content or found it useful and educational, please share this article with your friends and family.


Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs, propublica.org

Leave a comment

Be part of the conversation by becoming a Premium Member. Click here to learn more about membership.

Leave a Reply

Your email address will not be published. Required fields are marked *